India bans export of remedicies as a result of COVID-19 case India News


The health ministry says a seven-day record of new infections shows India growing every day and the ban should be enforced “until the situation improves”.

India has banned the export of antiviral drug remedivir and its active drug ingredients as demand has risen amid a record increase in COVD-19 infections and a crisis in many parts of the country.

The number of new daily infections on Sunday stood at 152,879, the sixth highest increase in seven days, with hospitals in some regions irresistible. India, known as the world’s pharmacy, has already stopped large exports of the coronavirus vaccine.

In addition to the ban on remediation “until the situation improves,” the health ministry said in a statement that it had asked producers to increase supplies.

Seven Indian companies have licensed the drug from Gilead Sciences for local use for about 3.9 million units per month and for export to more than 100 countries.

In November, the World Health Organization issued a conditional recommendation against the use of remedicative in hospitalized patients, regardless of the severity of the disease, saying there was no evidence of drug survival and other consequences in these patients.

However, many countries, including India, continue to use it.

The death toll from the infection, which killed 639 people at the health ministry on Sunday, also rose to a maximum of 1,169,2755 in more than five months.

India has the third highest number of cases with more than 133.35 million cases compared to the United States and Brazil alone.

A so-called “vaccination festival” is being organized in the country to vaccinate the highest number of eligible people to prevent the virus.

The vaccination program will run till April 14, following an appeal by Prime Minister Narendra Modi to the chief ministers of the states at a meeting on the medical crisis.

The vaccination drive in India, which began earlier this year, has given 60 million front-line doses to people over the age of 45.

However, several states have claimed that they are facing vaccine shortages despite assurances from the government.

The federal health ministry has written to the Maharashtra government, which is based in the financial capital Mumbai, asking local authorities to improve the COVD-19 test and deploy more manpower.

“Recruitment of top health workers needs to be expedited to increase the number of health workers,” the letter from India’s top health official said, highlighting the acute shortage of health workers in seven districts of Maharashtra.

Authorities have blamed the resurgence of the virus mainly on crowds and reluctance to wear masks, and have even complained that election rallies and religious gatherings have continued in recent weeks.

Thousands of people flocked to the banks of the holy river Ganges in Haridwar on Sunday to pray during the Kumbh Mela – which is expected to draw five million devotees on a given day.

Authorities have made it mandatory for everyone entering the region to take the CVD-19 test. However, on Sunday, many fans gathered at the river bank without masks.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *